Request Demo
Last update 12 Aug 2025
TQC-3721
Last update 12 Aug 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms TQC 3721, TQC-3721, TQC3721 |
Target |
Action inhibitors |
Mechanism PDE3 inhibitors(Phosphodiesterase 3 inhibitors), PDE4 inhibitors(Phosphodieterase 4 inhibitors) |
Therapeutic Areas |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
RegulationBreakthrough Therapy (China) |
Login to view timeline
Related
7
Clinical Trials associated with TQC-3721NCT06748079
Phase I Clinical Study on the Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Characteristics of Single/Multiple Dose Escalation of TQC3721 Inhalation Powder in Patients With Chronic Obstructive Pulmonary Disease
NCT06527144
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Clinical Trial of the Efficacy and Safety of Inhaled TQC3721 Suspension in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
CTR20242692
吸入用TQC3721 混悬液在中重度慢性阻塞性肺疾病患者中有效性和安全性的多中心、随机、双盲、安慰剂对照II 期临床试验
[Translation] A multicenter, randomized, double-blind, placebo-controlled phase II clinical trial of the efficacy and safety of TQC3721 suspension for inhalation in patients with moderate to severe chronic obstructive pulmonary disease
100 Clinical Results associated with TQC-3721
Login to view more data
100 Translational Medicine associated with TQC-3721
Login to view more data
100 Patents (Medical) associated with TQC-3721
Login to view more data
100 Deals associated with TQC-3721
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Moderate chronic obstructive pulmonary disease | Phase 3 | China | 06 Aug 2025 | |
| Severe chronic obstructive pulmonary disease | Phase 3 | China | 06 Aug 2025 | |
| Asthma | Phase 1 | China | 18 Oct 2021 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free